Hydroxyurea and Pain History in Relation to Patient-Reported Outcomes Using PROMIS Measures and the Frequency of Assessments in Sickle Cell Disease Patients

Sherif M Badawy*

*Corresponding author for this work

Research output: Contribution to journalLetter

2 Citations (Scopus)
Original languageEnglish (US)
Number of pages1
JournalPediatric Blood and Cancer
Volume64
Issue number1
DOIs
StatePublished - Jan 1 2017

Fingerprint

Hydroxyurea
Sickle Cell Anemia
Pain
Patient Reported Outcome Measures

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Cite this

@article{1c3e21a987d34c4098115b199181b3ea,
title = "Hydroxyurea and Pain History in Relation to Patient-Reported Outcomes Using PROMIS Measures and the Frequency of Assessments in Sickle Cell Disease Patients",
author = "Badawy, {Sherif M}",
year = "2017",
month = "1",
day = "1",
doi = "10.1002/pbc.26059",
language = "English (US)",
volume = "64",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Hydroxyurea and Pain History in Relation to Patient-Reported Outcomes Using PROMIS Measures and the Frequency of Assessments in Sickle Cell Disease Patients

AU - Badawy, Sherif M

PY - 2017/1/1

Y1 - 2017/1/1

UR - http://www.scopus.com/inward/record.url?scp=84971273159&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84971273159&partnerID=8YFLogxK

U2 - 10.1002/pbc.26059

DO - 10.1002/pbc.26059

M3 - Letter

VL - 64

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 1

ER -